Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The IARC TP53 database: new online mutation analysis and recommendations to users.

Magali Olivier1, Ros Eeles, Monica Hollstein

  • 1Molecular Carcinogenesis Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.

Human Mutation
|May 15, 2002
PubMed
Summary

The International Agency for Research on Cancer (IARC) TP53 mutation database now features a patient-centered structure and an online tool for analyzing cancer mutation patterns. This resource aids in understanding cancer development and TP53 gene variations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The urinary-metabolite-based lung cancer index (uLCI): an interpretable machine-learning risk model for early-stage disease.

medRxiv : the preprint server for health sciences·2026
Same author

Clinical characteristics, causative organisms, and antimicrobial resistance profiles of hospital-acquired invasive gram-negative bacterial infections at a tertiary-care center in Saudi Arabia: a five-year retrospective cohort study (2020-2024).

BMC infectious diseases·2026
Same author

The senescence-inhibitory p53 isoform Δ133p53α represses the proinflammatory chemokine CXCL10 in progeria model mice and naturally aged mice.

bioRxiv : the preprint server for biology·2026
Same author

Glenolabral articular disruption lesions are not associated with increased risk of recurrent instability following arthroscopic Bankart repair: A systematic review.

Shoulder & elbow·2026
Same author

Projected impact of a pathogen reduction intervention on carbapenem-resistant Enterobacterales bloodstream infections and deaths in the United States.

Infection control and hospital epidemiology·2026
Same author

Senescence-inhibitory Δ133p53α counteracts accelerated ageing and mortality.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Oncology
  • Genetics
  • Bioinformatics

Background:

  • TP53 gene mutations are prevalent across numerous human cancers.
  • Analyzing TP53 mutation patterns across different cancer types can offer insights into disease progression.
  • Several TP53 mutation databases have been established, with the IARC database being the most comprehensive.

Purpose of the Study:

  • To describe recent enhancements to the IARC TP53 mutation database.
  • To introduce a new patient-centered structure and an online analysis tool.
  • To provide guidance on database utilization and limitations.

Main Methods:

  • Compilation of all reported TP53 mutations (somatic and inherited) and polymorphisms since 1989 from published literature.
  • Restructuring the database to be patient-centered with enhanced annotations (carcinogen exposure, virus infection, genetic background).

Related Experiment Videos

  • Development of a new online application for retrieving somatic mutation data and analyzing mutation patterns.
  • Main Results:

    • The IARC TP53 mutation dataset is the largest available for any human gene.
    • The database now offers a more detailed, patient-focused view of TP53 variations.
    • A functional online tool is available for querying and analyzing somatic mutation data.

    Conclusions:

    • The updated IARC TP53 database provides a valuable resource for cancer research.
    • The new features facilitate deeper analysis of TP53 mutation patterns and their relation to patient factors.
    • Recommendations for effective database use are provided to researchers.